Category: Equity: Sectoral-Pharma and Healthcare |
Launch Date: 06-02-2024 |
Asset Class: |
Benchmark: BSE Healthcare TRI |
TER: 2.38% As on (31-05-2025) |
Status: Open Ended Schemes |
Minimum Investment: 500.0 |
Minimum Topup: 500.0 |
Total Assets: 330.49 Cr As on 30-05-2025(Source:AMFI) |
Turn over: - | Exit Load: 1.00% (of applicable NAV); if Units are redeemed/ switched-out within 1 month from the date of allotment. Nil thereafter |
Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)
To provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. There is no assurance that the investment objective of the Scheme will be achieved.
Standard Deviation | - |
Sharpe Ratio | - |
Alpha | - |
Beta | - |
Yield to Maturity | - |
Average Maturity | - |
Small Cap
38.73%
Others
6.12%
Large Cap
25.97%
Mid Cap
29.18%